June
Diabetes and the Changing NHS
Changing Pathways: What Life Sciences need to know about Diabetes care in today’s NHS
Shailen Rao explores the latest NHS strategies for Diabetes care, including prevention, technology adoption and integrated service delivery and what they mean for Life Sciences companies seeking to support pathway reform and improved outcomes.
Rare Disease: No HTA Approval? – No Problem!
From national roadblock to local breakthrough: practical pathways to Rare Disease funding
What happens when HTA approval isn’t achievable? Join market access expert Phil Cox to explore how Rare Disease teams can pivot from national roadblocks to targeted, high-impact NHS funding strategies for the most severely affected patients – even without formal approval.